Developer docs
API playgroundTry for free, no card

Search company profiles

Rhinostics

Full company profile

uuid0005wsa

Namestring
Rhinostics
Websiteurl
rhinostics.com
Company typeenum
Private
Founded yearint
2020
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
sample collection devices, automated nasal swabs, diagnostic specimen collection, blood collection devices, laboratory consumables
Industry2 codes
PRIMARYHLAHAIAK
Nasal Drug Delivery Devices (Sprays/Powder Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLAHAOAK
Home-Use & OTC Rapid Self-Tests (Consumer POCT kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Diagnostic specimen collection devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Sample Collection Device Sales
TypeHardware Sales
Description

Sale of automated nasal swab devices and other sample collection technologies to laboratories and healthcare facilities

zpr.io
Cost components5 values
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Rhinostics manufactures automated sample collection devices for clinical and diagnostic laboratory use. Its flagship product is a proprietary automated nasal swab intended to streamline specimen collection workflows, and the company is developing blood collection device technologies for diagnostic specimen collection.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Rhinostics offers a portfolio of automated sample collection devices for diagnostic applications. The core product is an automated nasal swab system designed to standardize and streamline specimen collection. The company is expanding its product line to include blood collection devices, positioning itself as a provider of comprehensive sample collection solutions for laboratory and clinical settings.

Product and service1 record
1Automated Nasal Swab
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Manufacturer of Tasso OnDemand, a capillary blood microsampling device for decentralized sample collection. Comparable to Rhinostics' planned blood collection extension in the at-home and clinical capillary sampling category.

TypeBroad incumbent
Description

Specialist in oral fluid and other non-invasive sample collection devices for diagnostics. Comparable to Rhinostics in the alternative specimen collection category for clinical and at-home testing.

TypeDirect peer
Description

Major U.S. manufacturer of single-use specimen collection swabs, including nasopharyngeal and nasal swabs used in clinical diagnostics. Closest direct competitor to Rhinostics' core product line.

TypeBroad incumbent
Description

Global medical device incumbent with a large diagnostic specimen collection and microbiology portfolio (BD ESwab, BD MAX). Competes broadly with Rhinostics in clinical lab sample collection consumables.

TypeDirect peer
Description

Established manufacturer of flocked swabs and automated sample-collection/pre-analytical systems (e.g., WASP, WASPLab). Directly comparable to Rhinostics in the automated nasal swab and laboratory accessioning workflow category.

TypeRegional player
Description

U.S.-based manufacturer and distributor of microbiology specimen collection and transport devices serving clinical laboratories. Directly comparable to Rhinostics on specimen collection consumables sold into clinical labs.

TypeEmerging player
Description

Maker of the TAP II device for virtually painless capillary blood collection. Comparable to Rhinostics on the automated specimen collection mechanism and decentralized clinical sampling positioning.

8Seventh Sense Biosystems
TypeEmerging player
Description

Developer of the TAP device for push-button capillary blood collection. Competes in the same emerging minimally-invasive sample collection space as Rhinostics' blood collection roadmap.

TypeEmerging player
Description

Developer of needle-free blood collection technology for hospital settings. Directly comparable to Rhinostics' blood-collection device extension — both pursue less-invasive specimen collection adjacent to traditional venipuncture.

TypeEmerging player
Description

Manufacturer of the Mitra microsampling device for volumetric absorptive microsampling. Comparable to Rhinostics in alternative sample collection formats targeting clinical and remote testing workflows.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rhinostics

Diagnostic specimen collection devicesrhinostics.com

Rhinostics firmographics

Firmographics
Name
Rhinostics
Website
https://rhinostics.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Rhinostics industry classification

Industry
Product category
Diagnostic specimen collection devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAIAK
Nasal Drug Delivery Devices (Sprays/Powder Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLAHAOAK
Home-Use & OTC Rapid Self-Tests (Consumer POCT kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics

Keywords

  • Sample collection devices
  • Automated nasal swabs
  • Diagnostic specimen collection
  • Blood collection devices
  • Laboratory consumables

Where Rhinostics is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Markets served

Rhinostics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Revenue model

  1. Sample Collection Device Sales: Sale of automated nasal swab devices and other sample collection technologies to laboratories and healthcare facilities

Go-to-market motion1 record

Rhinostics product offering

Product offering

Core offering

Rhinostics manufactures automated sample collection devices for clinical and diagnostic laboratory use. Its flagship product is a proprietary automated nasal swab intended to streamline specimen collection workflows, and the company is developing blood collection device technologies for diagnostic specimen collection.

Product overview

Rhinostics offers a portfolio of automated sample collection devices for diagnostic applications. The core product is an automated nasal swab system designed to standardize and streamline specimen collection. The company is expanding its product line to include blood collection devices, positioning itself as a provider of comprehensive sample collection solutions for laboratory and clinical settings.

Differentiator

Problem solved

Functional benefit

Products and services

  • Automated Nasal Swab

Companies that use Rhinostics

Customer profile

Segments1 record

Ideal customer profiles1 record

Rhinostics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Rhinostics partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Rhinostics competitors and assessment

Company assessment

Emerging players

  • Tasso: Manufacturer of Tasso OnDemand, a capillary blood microsampling device for decentralized sample collection. Comparable to Rhinostics' planned blood collection extension in the at-home and clinical capillary sampling category.
  • Yourbio Health: Maker of the TAP II device for virtually painless capillary blood collection. Comparable to Rhinostics on the automated specimen collection mechanism and decentralized clinical sampling positioning.
  • Seventh Sense Biosystems: Developer of the TAP device for push-button capillary blood collection. Competes in the same emerging minimally-invasive sample collection space as Rhinostics' blood collection roadmap.
  • Velano Vascular: Developer of needle-free blood collection technology for hospital settings. Directly comparable to Rhinostics' blood-collection device extension — both pursue less-invasive specimen collection adjacent to traditional venipuncture.
  • Neoteryx (Trajan Scientific): Manufacturer of the Mitra microsampling device for volumetric absorptive microsampling. Comparable to Rhinostics in alternative sample collection formats targeting clinical and remote testing workflows.

Broad incumbents

  • OraSure Technologies: Specialist in oral fluid and other non-invasive sample collection devices for diagnostics. Comparable to Rhinostics in the alternative specimen collection category for clinical and at-home testing.
  • Becton, Dickinson and Company (BD): Global medical device incumbent with a large diagnostic specimen collection and microbiology portfolio (BD ESwab, BD MAX). Competes broadly with Rhinostics in clinical lab sample collection consumables.

Direct peers

  • Puritan Medical Products: Major U.S. manufacturer of single-use specimen collection swabs, including nasopharyngeal and nasal swabs used in clinical diagnostics. Closest direct competitor to Rhinostics' core product line.
  • Copan Diagnostics: Established manufacturer of flocked swabs and automated sample-collection/pre-analytical systems (e.g., WASP, WASPLab). Directly comparable to Rhinostics in the automated nasal swab and laboratory accessioning workflow category.

Regional players

  • Hardy Diagnostics: U.S.-based manufacturer and distributor of microbiology specimen collection and transport devices serving clinical laboratories. Directly comparable to Rhinostics on specimen collection consumables sold into clinical labs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

Rhinostics social profiles

Digital presence

Rhinostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rhinostics leadership team

Management profile

Number of profiles

Profiles5 records

Rhinostics funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rhinostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rhinostics

What does Rhinostics do?

Rhinostics manufactures automated sample collection devices for clinical and diagnostic laboratory use. Its flagship product is a proprietary automated nasal swab intended to streamline specimen collection workflows, and the company is developing blood collection device technologies for diagnostic specimen collection.

Is Rhinostics a public or private company?

Rhinostics is a private company. It is classified as venture growth investor backed and is currently operating.

When was Rhinostics founded?

Rhinostics was founded in 2020. It employs 1 to 10 people.

Where is Rhinostics based?

Rhinostics is headquartered in Boston, United States, in the North America region.

How does Rhinostics make money?

One revenue line is on record: sample Collection Device Sales.

Who are Rhinostics's main competitors?

Emerging players on record are Tasso, Yourbio Health, Seventh Sense Biosystems, Velano Vascular and Neoteryx (Trajan Scientific). Broad incumbents are OraSure Technologies and Becton, Dickinson and Company (BD). Direct peers are Puritan Medical Products and Copan Diagnostics. Hardy Diagnostics is listed as a regional player.

Does Rhinostics have an API?

No public API is recorded for Rhinostics.

What industry is Rhinostics in?

Rhinostics's product category is Diagnostic specimen collection devices. Its primary akta.pro industry code is HLAHAIAK, Nasal Drug Delivery Devices (Sprays/Powder Devices), with a secondary code of HLAHAOAK, Home-Use & OTC Rapid Self-Tests (Consumer POCT kits). Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogRhinostics Selected to Exhibit RHINOstic® Automated Swab Platform at Vizient Innovative Technology ExchangeRhinostics will exhibit its RHINOstic automated swab platform at Vizient's Innovative Technology Exchange on Oct. 3 in Grapevine, Texas. The system enables handsfree swab collection and robotic decapping, reducing manual steps and improving lab workflows. The company also highlights its broader family of automated sample collection devices.Business Wire BlogRhinostics and FutureMed Bring Innovative Dry Transport Technologies for Clinical Labs to Chile, developed amid the COVID-19 PandemicFutureMed and Rhinostics are bringing dry transport technologies to clinical labs in Chile, developed amid the COVID-19 pandemic. The technology improves sample concentration up to 30 times and lab efficiency up to 10 times, addressing challenges like painful sampling and reliance on viral transport medium.BioSpaceRhinostics Launches the VERIstic™ to Redefine Small Volume Blood CollectionRhinostics launched the VERIstic Collection Device for small-volume blood collection, combining capillary collection with an automation-ready cap. The device collects 50 µL of blood and enables 96 samples to be accessioned and processed robotically at the lab. The global debut will be at the 2022 AACC Annual Scientific Meeting in Chicago.Business Wire BlogRhinostics Launches the VERIstic™ to Redefine Small Volume Blood CollectionRhinostics launched the VERIstic Collection Device, a capillary blood collection system with an automation-ready cap. It collects 50 µL of blood per finger prick and enables 96 samples to be accessioned and processed at the laboratory. The device is designed for home and clinic use, with a global debut at the 2022 AACC meeting.Business Wire BlogRhinostics Launches the VERIstic™ to Redefine Small Volume Blood CollectionRhinostics launched the VERIstic Collection Device, a capillary blood collection system with an automation-ready cap. It collects 50 µL of blood per finger prick and enables 96 samples to be accessioned and processed at the lab. The device will debut at the 2022 AACC Annual Scientific Meeting in Chicago.Business Wire BlogRhinostics and Nexus Medical Labs Announce Partnership to Launch Rapid, Cost-Efficient Swab Sample Processing for Telehealth and Broader IndustriesNexus Medical Labs and Rhinostics announced a partnership to deploy the RHINOstic Automated Nasal Swab for swab-based testing. The device is expected to increase throughput, reduce labor costs, and improve assay results for COVID-19 and other analytes. Nexus processes up to 20,000 samples per day using the automated workflow.CincinnatiTest for COVID-19 at home? P&G pushes at-home swabProcter & Gamble licensed a nasal swab to Rhinostics for COVID-19 testing, with the firm planning to seek emergency use authorization in March. The swab allows home sample collection and mailing for lab testing, aiming to speed results and address supply bottlenecks.Business Wire BlogRapid, Cost-Efficient Sample Processing in Workflows such as COVID-19 Testing Enabled through Hamilton Storage and Rhinostics PartnershipHamilton Storage and Rhinostics announced a partnership to automate decapping and accessioning of patient samples for COVID-19 testing. The collaboration combines the LabElite DeCapper with the RHINOstic swab device, enabling dry shipment without viral transport media and increasing sample throughput. Additional functionality will be announced as it becomes available.